In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells (Q45855396)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 January 2006

Language	Label	Description	Also known as
English	In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells	scientific article published on 19 January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Karen E. Pollok

8

object named as

Karen E Pollok

1 reference

Europe PubMed Central

17 December 2017

author name string

Shanbao Cai

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Jennifer R Hartwell

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Ryan J Cooper

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Beth E Juliar

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Emi Kreklau

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Rafat Abonour

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

W Scott Goebel

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

publication date

19 January 2006

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

Molecular Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

13

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

1016-1026

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

DNA repair defects in stem cell function and aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

In vivo selection of MGMT(P140K) lentivirus–transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexp

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2005.11.017

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16426896

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45855396&oldid=2086700812"